Clinical Trial of a New Antidepressant (WY.3263)
- 1 September 1967
- journal article
- research article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 113 (502) , 999-1004
- https://doi.org/10.1192/bjp.113.502.999
Abstract
In the clinical evaluation of psychopharmacological agents there are many factors which operate simultaneously with the pharmacological effects. These other factors may independently have an effect on the patient's symptomatology. In uncontrolled studies, therefore, these “non-drug” factors may frequently lead to erroneous clinical conclusions in regard to drug efficacy as well as side reactions.This publication has 7 references indexed in Scilit:
- Nonblind Placebo TrialArchives of General Psychiatry, 1965
- NONBLIND PLACEBO TRIAL1965
- THE INFLUENCE OF DOCTORʼS ATTITUDE ON THE PATIENTʼS RESPONSE TO ANTIDEPRESSANT MEDICATIONJournal of Nervous & Mental Disease, 1963
- PSYCHOPHARMACOLOGIC AGENTSJournal of Nervous & Mental Disease, 1963
- THE DOCTOR-PATIENT RELATIONSHIP IN A PSYCHOPHARMACOLOGICAL TREATMENT SETTINGJournal of Nervous & Mental Disease, 1960
- A Contribution to the Methodology of Clinical Appraisal of Drug ActionPsychosomatic Medicine, 1959
- THE SYMPTOMATIC RELIEF OF ANXIETY WITH MEPROBAMATE, PHENOBARBITAL AND PLACEBOAmerican Journal of Psychiatry, 1959